Thyroid Eye DiseaseSymptoms, Doctors, Treatments, Advances & More
Thyroid Eye Disease Overview
Learn About Thyroid Eye Disease
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
MN - Cancer
Marius Stan is an Endocrinologist practicing medicine in Rochester, Minnesota. Dr. Stan is rated as an Elite provider by MediFind in the treatment of Thyroid Eye Disease. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Graves Disease, Hyperthyroidism, Thyroid Nodule, Thyroidectomy, and Ureteroscopy.
Office
Chrysoula Dosiou is an Endocrinologist practicing medicine in Stanford, California. Dr. Dosiou is rated as an Elite provider by MediFind in the treatment of Thyroid Eye Disease. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Thyroid Eye Disease, Graves Disease, Hyperthyroidism, and Thyroid Cancer.
Raymond Douglas M.D. PhD A Professional Corp.
Raymond Douglas is an Ophthalmologist practicing medicine in Beverly Hills, California. Dr. Douglas is rated as an Elite provider by MediFind in the treatment of Thyroid Eye Disease. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Thyroid Eye Disease, Graves Disease, Eyelid Drooping, and Ptosis.
Summary: The primary objective of Part A of this study is to investigate the safety and tolerability of AMG 732 after single subcutaneous (SC) doses. The primary objective of Part B of this study is to investigate the efficacy of AMG 732 in participants with Thyroid Eye Disease (TED) after multiple SC doses.
Summary: The primary objective of this study is to investigate the efficacy, safety, and tolerability of MHB018A, a humanized anti-IGF1R antibody, administered q4W for 6 months, in comparison to placebo, in the treatment of participants suffering from active TED.